Evidence map›Paper›PMID 39474037›Full record

ArticleTurkish journal of biology = Turk biyoloji dergisi2024

Delivery of

Zeynep Büşra Bolat, Ayça Ece Nezir, Ongun Mehmet Saka, Itır Ebru Zemheri, Sevgi Gülyüz, Umut Uğur Özköse, Özgür Yilmaz, Asuman Bozkir, Dilek Telci, Fikrettin Şahin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of biology = Turk biyoloji dergisi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zeynep Büşra BolatDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye.ORCID https://orcid.org/0000-0002-9216-6336
Ayça Ece NezirDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye.ORCID https://orcid.org/0000-0001-8229-1865
Ongun Mehmet SakaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-8726-6391
Itır Ebru ZemheriDepartment of Pathology, Umraniye Training and Research Hospital, İstanbul, Turkiye.ORCID https://orcid.org/0000-0003-0247-0332
Sevgi GülyüzMaterials Institute, Marmara Research Center, TÜBİTAK, Gebze, Turkiye.ORCID https://orcid.org/0000-0002-2576-3085
Umut Uğur ÖzköseMaterials Institute, Marmara Research Center, TÜBİTAK, Gebze, Turkiye.ORCID https://orcid.org/0000-0003-4807-6322
Özgür YilmazMaterials Institute, Marmara Research Center, TÜBİTAK, Gebze, Turkiye.ORCID https://orcid.org/0000-0003-3892-2775
Asuman BozkirDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-2782-3280
Dilek TelciDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye.ORCID https://orcid.org/0000-0002-2793-6533
Fikrettin ŞahinDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye.ORCID https://orcid.org/0000-0003-1503-5567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the most common cancers and a significant cause of death in females worldwide. For effective breast cancer treatment, using systems with a promising delivery of anticancer agents is an important strategy. Peptide 18 (P18), a tumor-homing peptide, shows a high binding affinity toward breast cancer cells. Nanoliposomes are known to have enhanced accumulation ability in tumors with longer systemic circulation. In this study, Poly (2-ethyl-2-oxazoline) (PEtOx) polymers conjugated with DOPE are used to prepare PEtOx-DOPE nanoliposomes.

Indexed as

BikDD geneBreast cancergene deliverynanoliposomestargeted therapy

Identifiers

PMID39474037
PMCPMC11518345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.